Background Although malaria control intervention has greatly decreased malaria morbidity
and mortality in many African countries, further decline in parasite prevalence has stagnated …

The development of artemisinin resistance in the Greater Mekong Subregion poses a
significant threat to malaria elimination. Artemisinin-based combination therapies including …

The efficacies of 3-day regimens of artemether–lumefantrine (AL), artesunate–amodiaquine
(AA), and dihydroartemisinin–piperaquine (DHP) were evaluated in 910 children< 5 years …

Abstract Background Since 2005, the Togo National Malaria Control Programme has
recommended two different formulations of artemisinin-based combination therapy (ACT) …

Abstract Background and Objective In light of funding constraints in Sub-Saharan Africa
(SSA), the value of research performed there must be increased. The objective of this study …

Background and Purpose The artemisinin derivative, artemether, has antimalarial activity
with potential neurotoxic and cardiotoxic effects. Artemether in nanocapsules (NC‐ATM) is …

Background The burden of malaria persists in sub-Saharan Africa and the emergence of
artemisinin resistance has introduced complexity to control efforts. Monitoring the efficacy of …

Background Anaemia is common in malaria. It is important to quantitate the risk of anaemia
and to distinguish factors related to the natural history of disease from potential drug toxicity …

Background Malaria endemic countries need to assess efficacy of anti-malarial treatments
on a regular basis. Moreover, resistance to artemisinin that is established across mainland …

Background Artemisinin-based combination treatments (ACTs) are the first-line treatments of
uncomplicated Plasmodium falciparum malaria in many endemic areas but there are few …